Intracutaneous Sterile Water and Diclofenac Sodium Injections in Renal Colic
Launched by SUEZ CANAL UNIVERSITY · Mar 28, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective two different treatments are for relieving the severe pain caused by renal colic, which is a condition often seen in emergency rooms. The treatments being compared are an injection of diclofenac sodium, a common pain reliever, and an injection of sterile water. Researchers will measure patients' pain levels using a simple scale to see which treatment works better.
To be eligible for this trial, participants need to be between 18 and 65 years old and experiencing renal colic while at the emergency department of the 30 June Center for Urology and Nephrology in Ismailia, Egypt. However, individuals with certain health conditions, such as heart problems or liver issues, or those who have allergies to the medications being used, cannot participate. If you join the study, you will receive one of the treatments and will help researchers understand which option provides better pain relief. This trial is not yet recruiting participants, so there will be more information available soon for anyone interested.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients between the ages of 18 and 65.
- • Patients with renal colic at the emergency department of the 30 June Center for Urology and Nephrology, Ismailia, Egypt.
- Exclusion Criteria:
- • Cardiovascular diseases.
- • Renal, and hepatic dysfunction.
- • Hypersensitivity to any of the used drugs.
- • Addiction or chronic use of opioids.
About Suez Canal University
Suez Canal University is a distinguished academic institution dedicated to advancing medical research and education in the region. As a clinical trial sponsor, the university focuses on conducting innovative studies that aim to enhance patient care and outcomes. Leveraging its strong network of healthcare professionals and state-of-the-art facilities, Suez Canal University fosters collaboration between researchers and clinicians to explore new therapeutic approaches and validate clinical practices. Committed to ethical standards and scientific rigor, the university plays a pivotal role in contributing to the global body of medical knowledge and improving healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported